Timothy Romberger Cyteir Therapeutics, Inc. (CYT) insider trading activity

CYT Quotes by TradingView

Timothy Romberger is Director of Cyteir Therapeutics, Inc.. Currently has a direct ownership of 369,448 shares of CYT, which is worth approximately $1.11 Million. The most recent transaction as insider was on Jun 22, 2021, when has been sold 79,060 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 369K
0% 3M change
0% 12M change
Total Value Held $1.11 Million

Timothy Romberger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2021
BUY
Conversion of derivative security
-
79,060 Added 17.63%
369,448 Common Stock
TR

Timothy Romberger

Director
Lexington, MA

Track Institutional and Insider Activities on CYT

Follow Cyteir Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYT shares.

Notify only if

Insider Trading

Get notified when an Cyteir Therapeutics, Inc. insider buys or sells CYT shares.

Notify only if

News

Receive news related to Cyteir Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYT